386 related articles for article (PubMed ID: 11175805)
41. An apparent paradox: chemokine receptor agonists can be used for anti-inflammatory therapy.
Ali S; O'Boyle G; Mellor P; Kirby JA
Mol Immunol; 2007 Mar; 44(7):1477-82. PubMed ID: 17000001
[TBL] [Abstract][Full Text] [Related]
42. Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice.
Wareing MD; Lyon AB; Lu B; Gerard C; Sarawar SR
J Leukoc Biol; 2004 Oct; 76(4):886-95. PubMed ID: 15240757
[TBL] [Abstract][Full Text] [Related]
43. Chemokines: multiple levels of leukocyte migration control.
Moser B; Wolf M; Walz A; Loetscher P
Trends Immunol; 2004 Feb; 25(2):75-84. PubMed ID: 15102366
[TBL] [Abstract][Full Text] [Related]
44. Differential expression of chemokines and chemokine receptors in inflammatory periapical diseases.
Silva TA; Garlet GP; Lara VS; Martins W; Silva JS; Cunha FQ
Oral Microbiol Immunol; 2005 Oct; 20(5):310-6. PubMed ID: 16101967
[TBL] [Abstract][Full Text] [Related]
45. CC chemokine receptor-coupled signalling pathways.
New DC; Wong YH
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Sep; 35(9):779-88. PubMed ID: 12958648
[TBL] [Abstract][Full Text] [Related]
46. Distinct motifs in the chemokine receptor CCR7 regulate signal transduction, receptor trafficking and chemotaxis.
Otero C; Eisele PS; Schaeuble K; Groettrup M; Legler DF
J Cell Sci; 2008 Aug; 121(Pt 16):2759-67. PubMed ID: 18664492
[TBL] [Abstract][Full Text] [Related]
47. Celebrating chemokines.
Nat Immunol; 2001 Feb; 2(2):89. PubMed ID: 11175797
[No Abstract] [Full Text] [Related]
48. Chemokines and chemokine receptors as novel therapeutic targets in rheumatoid arthritis (RA): inhibitory effects of traditional Chinese medicinal components.
Chen X; Oppenheim JJ; Howard OM
Cell Mol Immunol; 2004 Oct; 1(5):336-42. PubMed ID: 16285892
[TBL] [Abstract][Full Text] [Related]
49. Human pregnancy: the role of chemokine networks at the fetal-maternal interface.
Red-Horse K; Drake PM; Fisher SJ
Expert Rev Mol Med; 2004 May; 6(11):1-14. PubMed ID: 15130179
[TBL] [Abstract][Full Text] [Related]
50. Manipulating the chemokine-chemokine receptor network to treat cancer.
Ruffini PA; Morandi P; Cabioglu N; Altundag K; Cristofanilli M
Cancer; 2007 Jun; 109(12):2392-404. PubMed ID: 17503430
[TBL] [Abstract][Full Text] [Related]
51. The chemokine network: a target in cancer biology?
Slettenaar VI; Wilson JL
Adv Drug Deliv Rev; 2006 Oct; 58(8):962-74. PubMed ID: 16996642
[TBL] [Abstract][Full Text] [Related]
52. Chemokines at large: in-vivo mechanisms of their transport, presentation and clearance.
Colditz IG; Schneider MA; Pruenster M; Rot A
Thromb Haemost; 2007 May; 97(5):688-93. PubMed ID: 17479178
[TBL] [Abstract][Full Text] [Related]
53. A time-resolved fluorescent lanthanide (Eu)-GTP binding assay for chemokine receptors as targets in drug discovery.
Labrecque J; Wong RS; Fricker SP
Methods Mol Biol; 2009; 552():153-69. PubMed ID: 19513648
[TBL] [Abstract][Full Text] [Related]
54. Autoantigen signalling through chemokine receptors.
Howard OZ
Curr Opin Rheumatol; 2006 Nov; 18(6):642-6. PubMed ID: 17053513
[TBL] [Abstract][Full Text] [Related]
55. Professional and part-time chemokine decoys in the resolution of inflammation.
Hansell C; Nibbs R
Sci STKE; 2007 May; 2007(384):pe18. PubMed ID: 17473307
[TBL] [Abstract][Full Text] [Related]
56. Chapter 5. Multiple approaches to the study of chemokine receptor homo- and heterodimerization.
Rodríguez-Frade J; Muñoz LM; Mellado M
Methods Enzymol; 2009; 461():105-22. PubMed ID: 19480916
[TBL] [Abstract][Full Text] [Related]
57. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit chemokine production in activated microglia.
Delgado M; Jonakait GM; Ganea D
Glia; 2002 Aug; 39(2):148-61. PubMed ID: 12112366
[TBL] [Abstract][Full Text] [Related]
58. Endogenous ligand bias by chemokines: implications at the front lines of infection and leukocyte trafficking.
Zidar DA
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):120-31. PubMed ID: 21476969
[TBL] [Abstract][Full Text] [Related]
59. Analysis of homing receptor expression on infiltrating leukocytes in disease states.
Mariani M; Panina-Bordignon P
J Immunol Methods; 2003 Feb; 273(1-2):103-14. PubMed ID: 12535801
[TBL] [Abstract][Full Text] [Related]
60. Human chemokines: an update.
Baggiolini M; Dewald B; Moser B
Annu Rev Immunol; 1997; 15():675-705. PubMed ID: 9143704
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
